1 - 25 of
64
results
for author:"Shah N."
in Literature Citations
| Impact of schizophrenia-risk gene dysbindin 1 on brain activation in bilateral middle frontal gyrus during a working memory task in healthy individuals. Markov V., Krug A., Krach S., Jansen A., Eggermann T., Zerres K., Stocker T., Shah N.J., Nothen M.M., Treutlein J. et al. Hum Brain Mapp 0:0-0(2009) · Mapped (2) |
| The impact of dystrobrevin-binding protein 1 (DTNBP1) on neural correlates of episodic memory encoding and retrieval. Thimm M., Krug A., Markov V., Krach S., Jansen A., Zerres K., Eggermann T., Stocker T., Shah N.J., Nothen M.M. et al. Hum Brain Mapp 0:0-0(2009) · Mapped (2) |
| Genetic variation in schizophrenia-risk-gene dysbindin 1 modulates brain activation in anterior cingulate cortex and right temporal gyrus during language production in healthy individuals. Markov V., Krug A., Krach S., Whitney C., Eggermann T., Zerres K., Stocker T., Shah N.J., Nothen M.M., Treutlein J. et al. Neuroimage 47:2016-2022(2009) · Mapped (2) |
| The effect of the COMT val(158)met polymorphism on neural correlates of semantic verbal fluency. Krug A., Markov V., Sheldrick A., Krach S., Jansen A., Zerres K., Eggermann T., Stocker T., Shah N.J., Kircher T. Eur Arch Psychiatry Clin Neurosci 259:459-465(2009) · Mapped (8) |
| Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Mahowald M.A., Rey F.E., Seedorf H., Turnbaugh P.J., Fulton R.S., Wollam A., Shah N., Wang C., Magrini V., Wilson R.K. et al. Proc. Natl. Acad. Sci. U.S.A. 106:5859-5864(2009) · UniProtKB (6,306) |
| The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome. Soong R., Shah N., Peh B.K., Chong P.Y., Ng S.S., Zeps N., Joseph D., Salto-Tellez M., Iacopetta B., Ito Y. Br. J. Cancer 100:676-679(2009) · Mapped (6) |
| Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome. Mukherjee S., Shaikh N., Khavale S., Shinde G., Meherji P., Shah N., Maitra A. Eur. J. Endocrinol. 160:855-862(2009) · Mapped (11) |
| A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe. Jansen A., Krach S., Krug A., Markov V., Eggermann T., Zerres K., Stocker T., Shah N.J., Nothen M.M., Treutlein J. et al. Neuroimage 45:1002-1008(2009) · Mapped (6) |
| Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis. Reiss A.B., Wan D.W., Anwar K., Merrill J.T., Wirkowski P.A., Shah N., Cronstein B.N., Chan E.S., Carsons S.E. Exp. Biol. Med. (Maywood) 234:354-360(2009) · Mapped (12) |
| Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis. Shah N.P., Kasap C., Weier C., Balbas M., Nicoll J.M., Bleickardt E., Nicaise C., Sawyers C.L. Cancer Cell 14:485-493(2008) · Mapped (40) |
| Triple A syndrome. Menon S.K., Bangar T.R., Kaba A., Shah R., Menon P.S., Shah N.S. Indian J Pediatr 75:967-967(2008) · Mapped (4) |
| CARF Is a vital dual regulator of cellular senescence and apoptosis. Hasan K., Cheung C., Kaul Z., Shah N., Sakaushi S., Sugimoto K., Oka S., Kaul S.C., Wadhwa R. J. Biol. Chem. 284:1664-1672(2009) · Mapped (31) |
| Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Kircher T., Thienel R., Wagner M., Reske M., Habel U., Kellermann T., Frommann I., Schwab S., Wolwer W., von Wilmsdorf M. et al. Eur Arch Psychiatry Clin Neurosci 259:72-79(2009) · Mapped (26) |
| Genetic variation in the schizophrenia-risk gene neuregulin1 correlates with differences in frontal brain activation in a working memory task in healthy individuals. Krug A., Markov V., Eggermann T., Krach S., Zerres K., Stocker T., Shah N.J., Schneider F., Nothen M.M., Treutlein J. et al. Neuroimage 42:1569-1576(2008) · Mapped (26) |
| Golgi alpha-mannosidase II cleaves two sugars sequentially in the same catalytic site. Shah N., Kuntz D.A., Rose D.R. Proc. Natl. Acad. Sci. U.S.A. 105:9570-9575(2008) · Mapped (1) |
| Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia. Raufman J.P., Samimi R., Shah N., Khurana S., Shant J., Drachenberg C., Xie G., Wess J., Cheng K. Cancer Res. 68:3573-3578(2008) · Mapped (2) |
| PAX4 enhances beta-cell differentiation of human embryonic stem cells. Liew C.G., Shah N.N., Briston S.J., Shepherd R.M., Khoo C.P., Dunne M.J., Moore H.D., Cosgrove K.E., Andrews P.W. PLoS ONE 3:e1783-e1783(2008) · Mapped (5) |
| Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. Shah N.A., Antoine H.J., Pall M., Taylor K.D., Azziz R., Goodarzi M.O. J. Clin. Endocrinol. Metab. 93:1939-1945(2008) · Mapped (8) |
| TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. Choi J., Southworth L.K., Sarin K.Y., Venteicher A.S., Ma W., Chang W., Cheung P., Jun S., Artandi M.K., Shah N. et al. PLoS Genet. 4:e10-e10(2008) · Mapped (5) |
| Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Helgeson B.E., Tomlins S.A., Shah N., Laxman B., Cao Q., Prensner J.R., Cao X., Singla N., Montie J.E., Varambally S. et al. Cancer Res. 68:73-80(2008) · Mapped (10) |
| Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics. Choong L.Y., Lim S., Loh M.C., Man X., Chen Y., Toy W., Pan M., Chen C.S., Poonepalli A., Hande M.P. et al. Mol. Cancer Ther. 6:2828-2842(2007) · Mapped (15) |
| Abnormal social behaviors in mice lacking Fgf17. Scearce-Levie K., Roberson E.D., Gerstein H., Cholfin J.A., Mandiyan V.S., Shah N.M., Rubenstein J.L., Mucke L. Genes Brain Behav. 7:344-354(2008) · Mapped (4) |
| CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer. Liu Q., Teh M., Ito K., Shah N., Ito Y., Yeoh K.G. Mod. Pathol. 20:1286-1297(2007) · Mapped (1) |
| Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency. Shah N.P., Skaggs B.J., Branford S., Hughes T.P., Nicoll J.M., Paquette R.L., Sawyers C.L. J. Clin. Invest. 117:2562-2569(2007) · Mapped (40) |
| Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin. Urban T.J., Brown C., Castro R.A., Shah N., Mercer R., Huang Y., Brett C.M., Burchard E.G., Giacomini K.M. Clin. Pharmacol. Ther. 83:416-421(2008) · Mapped (1) |
